ABI/Invitrogen, Bruker/Serva Launch Rival Quantitative Labeling Reagents | GenomeWeb

SAN ANTONIO — Mass spec players Applied Biosystems and Bruker have each partnered with a consumables company to market new quantitative labeling technologies, the companies independently announced this week.

Applied Biosystems is partnering with Invitrogen to co-market its SILAC and its own well-known ICAT and iTRAQ labeling reagents, while Bruker will be sidling up with Heidelberg, Germany-based Serva Electrophoresis to market a new type of labeling reagent called ICPL. Both moves are designed to help all four companies gain broader markets.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.